(Q44440963)

English

Editorial Commentary: Fluconazole Plus Amphotericin B Combinations Are Not Contraindicated and May Add Benefit for the Treatment of Candidemia

scientific article published on May 8, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Editorial Commentary: Fluconazole Plus Amphotericin B Combinations Are Not Contraindicated and May Add Benefit for the Treatment of Candidemia (English)

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

contraindication

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Frank C Odds

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

8 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1229-1231

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

2

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

3

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Antimicrobial Agents and Chemotherapy

4

43

2116

author name string

Andes D

publication date

1999

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients

6

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Antimicrobial Agents and Chemotherapy

7

42

1382

author name string

Lewis RE

publication date

1998

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Antimicrobial Agents and Chemotherapy

8

40

2511

author name string

Vazquez JA

publication date

1996

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis

9

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism

10

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in Mice

11

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

12

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Therapy of experimental meningeal and disseminated cryptococcosis.

13

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Combination therapy in experimental invasive aspergillosis

14

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

The past, present and future of antimycotic combination therapy

15

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.

17

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

18

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis

19

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Use of amphotericin B with azole antifungal drugs: what are we doing?

20

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Antifungal combination therapy: where we stand

21

1 reference

https://api.crossref.org/works/10.1086/374856

2 January 2024

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44440963&oldid=2043201941"